| Autophagosome proteins LC3A, LC3B and LC3C have distinct subcellular distribution kinetics and expression in cancer cell lines MI Koukourakis, D Kalamida, A Giatromanolaki, CE Zois, E Sivridis, ... PloS one 10 (9), e0137675, 2015 | 204 | 2015 |
| Evaluation of the alamarblue assay for adherent cell irradiation experiments MA Zachari, PS Chondrou, SE Pouliliou, AG Mitrakas, I Abatzoglou, ... Dose-Response 12 (2), dose-response. 13-024. Koukourakis, 2014 | 86 | 2014 |
| Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve MI Koukourakis, AG Mitrakas, A Giatromanolaki British journal of cancer 114 (5), 485-496, 2016 | 84 | 2016 |
| Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression D Kalamida, IV Karagounis, A Mitrakas, S Kalamida, A Giatromanolaki, ... PLoS One 10 (1), e0116021, 2015 | 81 | 2015 |
| Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts MI Koukourakis, D Kalamida, AG Mitrakas, M Liousia, S Pouliliou, ... Laboratory investigation 97 (11), 1321-1331, 2017 | 56 | 2017 |
| Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways A Giatromanolaki, M Kouroupi, S Pouliliou, A Mitrakas, F Hasan, A Pappa, ... Life sciences 259, 118389, 2020 | 48 | 2020 |
| Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis A Giatromanolaki, IM Koukourakis, K Balaska, AG Mitrakas, AL Harris, ... Medical Oncology 36, 1-12, 2019 | 47 | 2019 |
| Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy IV Karagounis, D Kalamida, A Mitrakas, S Pouliliou, MV Liousia, ... British journal of cancer 115 (3), 312-321, 2016 | 42 | 2016 |
| Intensified autophagy compromises the efficacy of radiotherapy against prostate cancer MI Koukourakis, D Kalamida, A Mitrakas, S Pouliliou, S Kalamida, ... Biochemical and biophysical research communications 461 (2), 268-274, 2015 | 38 | 2015 |
| CYP17A1 and androgen-receptor expression in prostate carcinoma tissues and cancer cell lines A Giatromanolaki, V Fasoulaki, D Kalamida, A Mitrakas, C Kakouratos, ... Current urology 13 (3), 157-165, 2019 | 34 | 2019 |
| Expression of CD47 and SIRPα macrophage immune-checkpoint pathway in non-small-cell lung cancer A Giatromanolaki, A Mitrakas, I Anestopoulos, A Kontosis, IM Koukourakis, ... Cancers 14 (7), 1801, 2022 | 25 | 2022 |
| Structurally characterized copper-chrysin complexes display genotoxic and cytotoxic activity in human cells E Halevas, A Mitrakas, B Mavroidi, D Athanasiou, P Gkika, K Antoniou, ... Inorganica Chimica Acta 515, 120062, 2021 | 23 | 2021 |
| Comparison of the effect of the antiandrogen apalutamide (ARN-509) versus bicalutamide on the androgen receptor pathway in prostate cancer cell lines MI Koukourakis, C Kakouratos, D Kalamida, A Mitrakas, S Pouliliou, ... Anti-cancer drugs 29 (4), 323-333, 2018 | 22 | 2018 |
| Autophagic flux response and glioblastoma sensitivity to radiation AG Mitrakas, D Kalamida, A Giatromanolaki, S Pouliliou, A Tsolou, ... Cancer Biology & Medicine 15 (3), 260, 2018 | 21 | 2018 |
| Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity AG Mitrakas, D Kalamida, MI Koukourakis Anti-cancer drugs 25 (10), 1182-1191, 2014 | 21 | 2014 |
| Increased soluble PD-L1 levels in the plasma of patients with epithelial ovarian cancer correlate with plasma levels of miR34a and miR200 MI Koukourakis, E Kontomanolis, M Sotiropoulou, A Mitrakas, E Dafa, ... Anticancer Research 38 (10), 5739-5745, 2018 | 19 | 2018 |
| Prognostic relevance of the relative presence of CD4, CD8 and CD20 expressing tumor infiltrating lymphocytes in operable non-small cell lung cancer patients A Giatromanolaki, I Anestopoulos, MI Panayiotidis, A Mitrakas, A Pappa, ... Anticancer Research 41 (8), 3989-3995, 2021 | 17 | 2021 |
| Differential effect of hypoxia and acidity on lung cancer cell and fibroblast metabolism A Giatromanolaki, M Liousia, S Arelaki, D Kalamida, S Pouliliou, ... Biochemistry and Cell Biology 95 (3), 428-436, 2017 | 15 | 2017 |
| Loss of HLA-class-I expression in non-small-cell lung cancer: association with prognosis and anaerobic metabolism IM Koukourakis, A Giatromanolaki, A Mitrakas, MI Koukourakis Cellular Immunology 373, 104495, 2022 | 13 | 2022 |
| SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy MI Koukourakis, A Giatromanolaki, K Fylaktakidou, E Sivridis, CE Zois, ... Investigational New Drugs 36, 773-781, 2018 | 12 | 2018 |
